<doc>
  <docmeta id="113s907is">
    <bill congress="113" type="s" number="907" version="is"/>
    <revision size="11179" annotations="0" status="complete" id="4" commit-time="2013-07-30T21:35:27Z" committer="mbohmer" doc="113s907is/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S907 IS: Gestational Diabetes Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2013-05-08</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 907</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130508">May 8, 2013</action-date>
			<action-desc>
        <sponsor name-id="S324">Mrs. Shaheen</sponsor> (for
			 herself and <cosponsor name-id="S252">Ms. Collins</cosponsor>) introduced the
			 following bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To provide grants to better understand and reduce
		  gestational diabetes, and for other purposes. </official-title>
	</form>
	<legis-body id="HEDC8FD49D1634970B9734338D9170CF4" style="OLC">
		<section id="H215C682BD0C3475D9BDD71E64B543496" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Gestational Diabetes
			 Act</short-title>
        </quote> or the <quote>
          <short-title>GEDI
			 Act</short-title>
        </quote>.</text>
		</section>
    <section id="HCAC400C8521F41C7891EBC0B27670A8A">
      <enum>2.</enum>
      <header>Gestational
			 diabetes</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act/t:III/pt:B">Part B of title III
			 of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/243">
            <cato:entity-ref entity-type="uscode" value="usc/42/243/etseq">42 U.S.C. 243 et seq.</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding
			 after section 317H the following:</text>
			<quoted-block display-inline="no-display-inline" id="H9F14378FABDA442B9BFB498602FAAF63" style="OLC">
				<section id="H711E1E7B087046B59D12B1025EC98BF1">
          <enum>317H–1.</enum>
          <header>Gestational
				diabetes</header>
					<subsection id="H9D426F9B88B34D5A8EF367B2C804A192">
            <enum>(a)</enum>
            <header>Understanding
				and monitoring gestational diabetes</header>
						<paragraph id="H9EC38A54183F418487E9F19269331A37">
              <enum>(1)</enum>
              <header>In
				general</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers
				for Disease Control and Prevention</cato:entity-ref>, in consultation with the Diabetes Mellitus
				Interagency Coordinating Committee established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:429">section 429</cato:entity-ref> and
				representatives of appropriate national health organizations, shall develop a
				multisite gestational diabetes research project within the diabetes program of
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease Control and Prevention</cato:entity-ref> to expand and enhance
				surveillance data and public health research on gestational diabetes.</text>
						</paragraph>
            <paragraph id="H3B64949DC8B54A09B70AACA3386FB319">
              <enum>(2)</enum>
              <header>Areas to be
				addressed</header>
              <text>The research project developed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:317H–1/ss:a/p:1" proposed="true">paragraph (1)</cato:entity-ref>
				shall address—</text>
							<subparagraph id="H73C8D39BFB05427B98422A4635E4F253">
                <enum>(A)</enum>
                <text>procedures to
				establish accurate and efficient systems for the collection of gestational
				diabetes data within each State, territory, and possession of the United
				States;</text>
							</subparagraph>
              <subparagraph id="H8D12BD0E33A04B56B3D89B2E8A6F0DFF">
                <enum>(B)</enum>
                <text>the progress of
				collaborative activities with the National Vital Statistics System, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Center for Health Statistics" entity-parent-id="7523">National Center for Health Statistics</cato:entity-ref>, and State health departments with
				respect to the standard birth certificate, in order to improve surveillance of
				gestational diabetes;</text>
							</subparagraph>
              <subparagraph id="H1ED01F9396B54B428D3107EA6C29B331">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">postpartum methods of tracking women with
				gestational diabetes after delivery and targeted interventions proven to lower
				the incidence of type 2 diabetes in that population;</text>
							</subparagraph>
              <subparagraph id="H9217E2EC18194B90A31109685FE5CB94">
                <enum>(D)</enum>
                <text>variations in the
				distribution of diagnosed and undiagnosed gestational diabetes, and of impaired
				fasting glucose tolerance and impaired fasting glucose, within and among groups
				of women; and</text>
							</subparagraph>
              <subparagraph id="HD03BB90AE83340BC9C1D0F84FBB2AE86">
                <enum>(E)</enum>
                <text>factors and
				culturally sensitive interventions that influence risks and reduce the
				incidence of gestational diabetes and related complications during childbirth,
				including cultural, behavioral, racial, ethnic, geographic, demographic,
				socioeconomic, and genetic factors.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="H03949B255DB94D6D8203259D83C5657C">
              <enum>(3)</enum>
              <header>Report</header>
              <text>Not
				later than 2 years after the date of the enactment of this section, and
				annually thereafter, the Secretary shall prepare a report on the findings and
				recommendations of the research project, including prevalence of gestational
				diabetes in the multisite area, and disseminate the report to the appropriate
				Federal and non-Federal agencies.</text>
						</paragraph>
          </subsection>
          <subsection id="H39314246C3DD4A5C82B01DC34CF4B7CB">
            <enum>(b)</enum>
            <header>Expansion of
				gestational diabetes research</header>
						<paragraph id="H78E02D11FA8244C6A7D4772C1E7CAA87">
              <enum>(1)</enum>
              <header>In
				General</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall
				expand and intensify public health research regarding gestational diabetes.
				Such research may include—</text>
							<subparagraph id="H7BDD69722598471A9819BD8DA20EE05F">
                <enum>(A)</enum>
                <text>developing and
				testing novel approaches for improving postpartum diabetes testing or screening
				and for preventing type 2 diabetes in women with a history of gestational
				diabetes; and</text>
							</subparagraph>
              <subparagraph id="HEE1BFF6A7ECE4BF386E5BDCD970E89CB">
                <enum>(B)</enum>
                <text>conducting public
				health research to further understanding of the epidemiologic,
				socioenvironmental, behavioral, translation, and biomedical factors and health
				systems that influence the risk of gestational diabetes and the development of
				type 2 diabetes in women with a history of gestational diabetes.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="H3539C04F0B134A859EF3703E8A0B8195">
              <enum>(2)</enum>
              <header>Authorization of
				Appropriations</header>
              <text>
                <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There is authorized to be appropriated <cato:property name="purpose">to carry
				out <cato:entity-ref entity-type="act" value="Public Health Service Act/s:317H–1/ss:b" proposed="true">this subsection</cato:entity-ref>
                  </cato:property> <cato:funds-and-year amount="5000000" year="2014, 2015, 2016, 2017, 2018">$5,000,000 for each of fiscal years 2014 through
				2018</cato:funds-and-year>.</cato:entity>
              </text>
						</paragraph>
          </subsection>
          <subsection id="HF0E604C1695E45AB833659B53342CA17">
            <enum>(c)</enum>
            <header>Demonstration
				grants To lower the rate of gestational diabetes</header>
						<paragraph id="H57859D46FB5347EABC4643306EDCA90B">
              <enum>(1)</enum>
              <header>In
				General</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting
				through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control and Prevention</cato:entity-ref>, shall
				award grants, on a competitive basis, to eligible entities for demonstration
				projects that implement evidence-based interventions to reduce the incidence of
				gestational diabetes, the recurrence of gestational diabetes in subsequent
				pregnancies, and the development of type 2 diabetes in women with a history of
				gestational diabetes.</text>
						</paragraph>
            <paragraph id="H5531ACD016904B70AA8D9778C3C13D6E">
              <enum>(2)</enum>
              <header>Priority</header>
              <text>In
				making grants under this subsection, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall give priority to
				projects focusing on—</text>
							<subparagraph id="H6ECD890FC731465EBCEA775392509D36">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">helping women who have 1 or more risk
				factors for developing gestational diabetes;</text>
							</subparagraph>
              <subparagraph id="H51E3C3E964E74425AA535B1256DEEA3C">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">working with women with a history of
				gestational diabetes during a previous pregnancy;</text>
							</subparagraph>
              <subparagraph id="H0FED3879F4D740EBA784F78C2EDBBA22">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">providing postpartum care for women with
				gestational diabetes;</text>
							</subparagraph>
              <subparagraph id="H1D664D7B02E04D7A848A7FC9BF5D2C75">
                <enum>(D)</enum>
                <text display-inline="yes-display-inline">tracking cases where women with a history
				of gestational diabetes developed type 2 diabetes;</text>
							</subparagraph>
              <subparagraph id="HA7BAFA1F096746648E8FCBA86FE20E10">
                <enum>(E)</enum>
                <text display-inline="yes-display-inline">educating mothers with a history of
				gestational diabetes about the increased risk of their children developing
				diabetes;</text>
							</subparagraph>
              <subparagraph id="H93AC71B020B547C5976DA1B9929FE4C2">
                <enum>(F)</enum>
                <text display-inline="yes-display-inline">working to prevent gestational diabetes and
				prevent or delay the development of type 2 diabetes in women with a history of
				gestational diabetes; and</text>
							</subparagraph>
              <subparagraph id="HA801C9D176C34E618FB56925C1A40643">
                <enum>(G)</enum>
                <text display-inline="yes-display-inline">achieving outcomes designed to assess the
				efficacy and cost-effectiveness of interventions that can inform decisions on
				long-term sustainability, including third-party reimbursement.</text>
							</subparagraph>
            </paragraph>
            <paragraph id="HCE3663C248FE4DAD8E0A556DC57A5AE4">
              <enum>(3)</enum>
              <header>Application</header>
              <text>An
				eligible entity desiring to receive a grant under this subsection shall submit
				to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>—</text>
							<subparagraph id="H2018472E6A9742CDA3381325290ACF66">
                <enum>(A)</enum>
                <text>an application at
				such time, in such manner, and containing such information as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may
				require; and</text>
							</subparagraph>
              <subparagraph id="HDB597D152A614367AD4171947736F053">
                <enum>(B)</enum>
                <text>a plan to—</text>
								<clause id="H60F20805754F4E1E830085D442A07CB7">
                  <enum>(i)</enum>
                  <text>lower the rate of
				gestational diabetes during pregnancy; or</text>
								</clause>
                <clause id="H81CE3D6F0469463985E2D75F73CD0F38">
                  <enum>(ii)</enum>
                  <text display-inline="yes-display-inline">develop methods of tracking women with a
				history of gestational diabetes and develop effective interventions to lower
				the incidence of the recurrence of gestational diabetes in subsequent
				pregnancies and the development of type 2 diabetes.</text>
								</clause>
              </subparagraph>
            </paragraph>
            <paragraph id="H0B211268B19E493CAAC7C19911359347">
              <enum>(4)</enum>
              <header>Uses of
				Funds</header>
              <text>An eligible entity receiving a grant under this subsection
				shall use the grant funds to carry out demonstration projects described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:317H–1/ss:c/p:1" proposed="true">paragraph (1)</cato:entity-ref>, including—</text>
							<subparagraph id="HED675B8EE0604709996BEDE0245BB33A">
                <enum>(A)</enum>
                <text>expanding
				community-based health promotion education, activities, and incentives focused
				on the prevention of gestational diabetes and development of type 2 diabetes in
				women with a history of gestational diabetes;</text>
							</subparagraph>
              <subparagraph id="H6ACDB7FA988C4AB28D675F4AD6B63187">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">aiding State- and tribal-based diabetes
				prevention and control programs to collect, analyze, disseminate, and report
				surveillance data on women with, and at risk for, gestational diabetes, the
				recurrence of gestational diabetes in subsequent pregnancies, and, for women
				with a history of gestational diabetes, the development of type 2 diabetes;
				and</text>
							</subparagraph>
              <subparagraph id="HC516ADF5D67E4AC5B29198A143BC77A6">
                <enum>(C)</enum>
                <text>training and
				encouraging health care providers—</text>
								<clause id="H4154DC485C014D92AA0C7CB2384CE8B1">
                  <enum>(i)</enum>
                  <text>to
				promote risk assessment, high-quality care, and self-management for gestational
				diabetes and the recurrence of gestational diabetes in subsequent pregnancies;
				and</text>
								</clause>
                <clause id="H29EEBE335DDC4BA8ADFF04876D31AD34">
                  <enum>(ii)</enum>
                  <text>to prevent the
				development of type 2 diabetes in women with a history of gestational diabetes,
				and its complications in the practice settings of the health care
				providers.</text>
								</clause>
              </subparagraph>
            </paragraph>
            <paragraph id="HBD508F32E6EA474BA2146B84EA09556D">
              <enum>(5)</enum>
              <header>Report</header>
              <text display-inline="yes-display-inline">Not later than 4 years after the date of
				the enactment of this section, the Secretary shall prepare and submit to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> a report concerning the results of the demonstration projects
				conducted through the grants awarded under this subsection.</text>
						</paragraph>
            <paragraph id="H7F7C680669164C70BB5636EA686A8EA0">
              <enum>(6)</enum>
              <header>Definition of
				Eligible Entity</header>
              <text>In this subsection, the term <term>eligible
				entity</term> means a nonprofit organization (such as a nonprofit academic
				center or community health center) or a State, tribal, or local health
				agency.</text>
						</paragraph>
            <paragraph id="H8364C92DC8F5454EA9D2A508844F4295">
              <enum>(7)</enum>
              <header>Authorization of
				Appropriations</header>
              <text>
                <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There is authorized to be appropriated <cato:property name="purpose">to carry
				out <cato:entity-ref entity-type="act" value="Public Health Service Act/s:317H–1/ss:c" proposed="true">this subsection</cato:entity-ref>
                  </cato:property> <cato:funds-and-year amount="5000000" year="2014, 2015, 2016, 2017, 2018">$5,000,000 for each of fiscal years 2014 through
				2018</cato:funds-and-year>.</cato:entity>
              </text>
						</paragraph>
          </subsection>
          <subsection id="H05BF5F214BE443CD999E2B9EBD5155B8">
            <enum>(d)</enum>
            <header>Postpartum
				follow-Up regarding gestational diabetes</header>
            <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting
				through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control and Prevention</cato:entity-ref>, shall
				work with the State- and tribal-based diabetes prevention and control programs
				assisted by the Centers to encourage postpartum follow-up after gestational
				diabetes, as medically appropriate, for the purpose of reducing the incidence
				of gestational diabetes, the recurrence of gestational diabetes in subsequent
				pregnancies, the development of type 2 diabetes in women with a history of
				gestational diabetes, and related
				complications.</text>
					</subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
  </legis-body>
</bill>
</doc>